Observational studyBMC infectious diseases2021

Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.

Yojana Gokhale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.